Tech Transfer eNews Blog

Comings and Goings

By Jesse Schwartz
Published: January 20th, 2021

Paul Sandberg, senior vice president of the Research, Innovation & Knowledge Enterprise at the University of South Florida (USF), is resigning from his post and returning to the faculty. Sandberg has been at USF for over 30 years, serving as an administrator for the past 12.

“I am so proud of the work we have done together to forward the research enterprise at USF, and help USF become recognized as a research and innovation powerhouse throughout Florida, our nation and the world,” he wrote in an e-mail to colleagues

Sandberg will now serve as a distinguished professor in the USF Department of Neurosurgery and Brain Repair in the Morsani College of Medicine. “My largest passion has been research,” he comments. “I’m not a spring chicken. I really want to spend the last years of my career focused on that.”

USF president Steve Currall credits Sandberg for the growth of the university’s standing as a research institution. “USF now ranks in the top 50 universities, public or private, for research expenditures — an impressive statistic for a university of our relative youth,” Currall says. “We owe much of this success to USF’s faculty and the dedicated focus of the team at USF Research & Innovation, led by Senior Vice President Dr. Paul Sanberg since 2013.”

Source: Tampa Bay Times

– – – – – – – – – – – – – –

LifeX Labs, a start-up accelerator at the University of Pittsburgh, has chosen life sciences industry veteran Gerald J. Vardzel, Jr., to serve as president and CEO. In his new role, Vardzel will lead LifeX Labs’ efforts to help life science entrepreneurs build out their businesses and attract capital to turn their medical research into commercialized therapies.

“Our region has the infrastructure and resources to have a meaningful impact in the near term,” Vardzel says, “but we must leverage our existing strategic relationships while building new ones outside the region.”

Vardzel most recently served as president and director of Predictive Oncology, an AI company that develops personalized medical treatments. Prior to that, he was board chairman, president and CEO of Helomics, a life science company that was acquired by Predictive Oncology in 2019.

Source: Pittsburgh Post-Gazette

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment